Survival Analysis of Biliary Tract Cancer Cases in Turkey

Creative Commons License

Akca Z., Mutlu H., ERDEN A., BUYUKCELIK A., Cihan Y. B., GOKSU S. S., ...Daha Fazla

ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, cilt.15, sa.15, ss.6025-6027, 2014 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 15 Sayı: 15
  • Basım Tarihi: 2014
  • Doi Numarası: 10.7314/apjcp.2014.15.15.6025
  • Dergi Adı: ASIAN PACIFIC JOURNAL OF CANCER PREVENTION
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.6025-6027
  • Anahtar Kelimeler: Biliary tract cancer, cholangiocarcinoma, survival, gallbladder, Ampulla vateri, INTRAHEPATIC CHOLANGIOCARCINOMA, GEMCITABINE, COMBINATION, MANAGEMENT, CISPLATIN, THAILAND
  • Akdeniz Üniversitesi Adresli: Evet

Özet

Background: Because of the relative rarity of biliary tract cancers (BTCs), defining long term survival results is difficult. In the present study, we aimed to evaluate the survival of a series of cases in Turkey. Materials and Methods: A totally of 47 patients with billiary tract cancer from Mersin Goverment Hospital, Acibadem Kayseri Hospital and Kayseri Training and Research Hospital were analyzed retrospectively using hospital records between 2006-2012. Results: The median overall survival was 19.3 +/- 3.9 months for all patients. The median disease free and overall survivals were 24.3 +/- 5.3 and 44.1 +/- 12.9 months in patients in which radical surgery was performed, but in those with with inoperable disease they were only 5.3 +/- 1.5 and 10.7 +/- 3.2 months, respectively. Conclusions: BTCs have a poor prognosis. Surgery with a microscopic negative margin is still the only curative treatment.